Study finds increased risk of type 2 diabetes with statin use
The link between statin use and higher risk of diabetes is not new. Back in 2013, for example, Medical News Today reported on a study published in The BMJ that found certain statins - particularly atorvastatin (Lipitor),rosuvastatin (Crestor) and simvastatin (Zocor) - raised the risk of diabetes by up to 22%.
But according to the researchers of this latest study - including Prof. Markku Laakso of the Institute of Clinical Medicine at the University of Eastern Finland and Kuopio University Hospital in Finland - such studies have had numerous limitations.
The team explains that many of these studies have included selective populations, such as those at high risk of cardiovascular disease. As a result, findings may not be applicable to the general population.
The researchers also note that these studies have often included participants whose diabetes has been self-reported or based on their fasting glucose measurements, which may underestimate the actual number of incident diabetes cases.